Second-trimester amniotic fluid interleukin-10 concentration predicts preterm delivery

REFERENCES

• Romero R, Sirtori M, Oyarzun E, et at. Infection and labor, V: prevalence, microbiology, and clinical significance of in-traamniotic infection in women with preterm labor and intact membranes. Am J Obstet Gynecol 1989;161:817–24
   PubMed Web of Science ®Google Scholar
• Wahbeh CJ, Hill GB, Eden RD, et at. Intraamniotic bacterial colonization in preterm labor. Am J Obstet Gynecol 1984;148:739–43
   PubMed Web of Science ®Google Scholar
• Bobitt JR, Hayslip CC, Damato JD. Amniotic fluid infection as determined by transabdominal amniocentesis in patients with intact membranes in premature labor. Am J Obstet Gynecol 1981;140:947–52
   Google Scholar
• Gravett MG, Witkin SS, Haluska GJ, et at. An experimental model for intraamniotic infection and preterm labor in rhesus monkeys. Am J Obstet Gynecol 1994;171:1660–7
   PubMed Web of Science ®Google Scholar
• Hiller SL, Witkin SS, Krohn MA, et at. The relationship of amniotic fluid cytokines and preterm delivery, amniotic fluid infection, histologic chorioamnionitis, and chorioamnion infection. Am J Obstet Gynecol 1993;81:941–8
   Google Scholar
• Greig PC, Ernest JM, Teot L, et at. Amniotic fluid interleukin-6 levels correlate with histologic chorioamnionitis and amniotic fluid cultures in patients in premature labor with intact membranes. Am J Obstet Gynecol 1993;169:1035–44
   PubMed Web of Science ®Google Scholar
• Mitchell MD, Dudley DJ, Edwin SS, et at. Interleukin-6 stimulates prostaglandin production by human amnion and decidual cells. Eur J Pharmacol 1991;192:189–91
   PubMed Web of Science ®Google Scholar
• Cherouny PH, Pankuch GA, Romero R, et at. Neutrophil attractant/activating peptide- 1/interleukin-8: association with histologic chorioamnionitis, preterm delivery, and bioactive amniotic fluid leukoattractants. Am J Obstet Gynecol 1993;169:1299–303
   PubMed Web of Science ®Google Scholar
• Bobitt JR, Ledger WJ. Amniotic fluid analysis: its role in maternal and neonatal infection. Obstet Gynecol 1978;51:56–62
   PubMed Web of Science ®Google Scholar
• Cassell GH, Davis RO, Waites KB, et at. Isolation of Mycoplasma hominis and Ureaplasma urealyticum from amniotic fluid at 16-20 weeks of gestation: potential effect on outcome of pregnancy. Sex Transm Dis 1983;10 (Suppl 4):294–302
   PubMed Web of Science ®Google Scholar
• Goldstein I, Zimmer EX, Merzbach D, et at. Intraamniotic infection in the very early phase of the second trimester. Am J Obstet Gynecol 1990;163:1261–3
   PubMed Web of Science ®Google Scholar
• Gray DJ, Robinson HB, Malone J, et at. Adverse outcome in pregnancy following amniotic fluid isolation of Ureaplasma urealyticum. Prenat Diagn 1992;12:111–17
   PubMed Web of Science ®Google Scholar
• Ghidini G, Jenkins CB, Spong CY, et at. Elevated amniotic fluid interleukin-6 levels during the early second trimester are associated with greater risk of subsequent preterm delivery. Am J Reprod Immunol 1997;37:227–3
   PubMed Web of Science ®Google Scholar
• Wenstrom K, Andrews W, Hauth J, et at. Elevated second-trimester amniotic fluid interleukin-6 levels predict preterm delivery. Am J Obstet Gynecol 1998;178:546–50
   PubMed Web of Science ®Google Scholar
• Fiorentino DF, Zlotnik A, Mosmann TR, et at. IL-10 inhibits cytokine production by activated macrophages. J Immunol 1991;147:3815–22
   PubMed Web of Science ®Google Scholar
• Fortunato SJ, Menon RP, Swan KF, et at. Interleukin-10 inhibition of interleukin-6 in human amniochorionic mem-brane: transcriptional regulation. Am J Obstet Gynecol 1996;175:1057–65
   PubMed Web of Science ®Google Scholar
• Kuhn R, Lohler D, Rennick K, et at. Interleukin-10 deficient mice develop chronic enterocolitis. Cell 1993;75:263–74
   PubMed Web of Science ®Google Scholar
• Ishida H. Clinical implications of IL-10 in patients with immune and inflammatory diseases. Lymphokine Cytokine Res 1993;12:344 (abstr)
   Google Scholar
• Coultrip LL, Lien JM, Gomez R, et at. The value of amniotic fluid interleukin-6 determination in patients with preterm labor and intact membranes in the detection of microbial invasion of the amniotic cavity. Am J Obstet Gynecol 1994;171:901–11
   PubMed Web of Science ®Google Scholar
• Dudley DJ, Hunter C, Mitchell MD, et at. Clinical value of amniotic fluid interleukin-6 determinations in the manage-ment of preterm labor. Br J Obstet Gynaecol 1994;101:592–7
   PubMedGoogle Scholar
• Romero R, Avila C, Santhanam U, et at. Amniotic fluid interleukin-6 in preterm labor: association with infection. J Clin Invest 1990;85:1392–400
   PubMed Web of Science ®Google Scholar
• Greig PC, Ernest JM, Erikson M, et at. Amniotic fluid interleukin-6 levels correlate with histologic chorioamnioni-tis and amniotic fluid cultures in patients in premature labor with intact membranes. Am J Obstet Gynecol 1993;169:1035–44
   PubMed Web of Science ®Google Scholar
• Dudley DJ, Hunter C, Mitchell M, et at. Amniotic fluid interleukin-10 concentrations during pregnancy and with labor. Am J Reprod Immunol 1997;33:147–56
   Web of Science ®Google Scholar
• Greig PC, Herbert WNP, Robinette BL, et at. Amniotic fluid interleukin-10 concentrations increase through pregnancy and are elevated in patients with preterm labor associated with intrauterine infection. Am J Obstet Gynecol 1995;173:1223–7
   PubMed Web of Science ®Google Scholar
• Heyborne K, McGregor JA, Henry G, et at. Interleukin-10 in amniotic fluid at midtrimester: immune activation and suppression in relation to fetal growth. Am J Obstet Gynecol 1994;171:55–9
   PubMed Web of Science ®Google Scholar
• Dudley DJ, Dangerfield A, Edwin SS. Interleukin-10 (IL-10) prevents preterm birth in a mouse model of infection-mediated preterm labor. J Soc Gynecol Invest 1996;3 (Suppl 2): 67A
   Google Scholar